825 related articles for article (PubMed ID: 20014921)
21. Functional synergies yet distinct modulators affected by genetic alterations in common human cancers.
Bessarabova M; Pustovalova O; Shi W; Serebriyskaya T; Ishkin A; Polyak K; Velculescu VE; Nikolskaya T; Nikolsky Y
Cancer Res; 2011 May; 71(10):3471-81. PubMed ID: 21398405
[TBL] [Abstract][Full Text] [Related]
22. Impact of genomics on personalized cancer medicine.
Arteaga CL; Baselga J
Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
[TBL] [Abstract][Full Text] [Related]
23. Overview of personalized medicine in the disease genomic era.
Hong KW; Oh B
BMB Rep; 2010 Oct; 43(10):643-8. PubMed ID: 21034525
[TBL] [Abstract][Full Text] [Related]
24. Prospects for personalized medicine with inhibitors targeting the RAS and PI3K pathways.
Lackner MR
Expert Rev Mol Diagn; 2010 Jan; 10(1):75-87. PubMed ID: 20014924
[TBL] [Abstract][Full Text] [Related]
25. Application of expression genomics for predicting treatment response in cancer.
Chin KV; Alabanza L; Fujii K; Kudoh K; Kita T; Kikuchi Y; Selvanayagam ZE; Wong YF; Lin Y; Shih WC
Ann N Y Acad Sci; 2005 Nov; 1058():186-95. PubMed ID: 16394136
[TBL] [Abstract][Full Text] [Related]
26. Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery.
Roukos DH
Expert Rev Mol Diagn; 2008 Sep; 8(5):587-97. PubMed ID: 18785807
[TBL] [Abstract][Full Text] [Related]
27. Future perspectives of personalized oncology.
Stambuk S; Sundov D; Kuret S; Beljan R; Andelinović S
Coll Antropol; 2010 Jun; 34(2):763-9. PubMed ID: 20698168
[TBL] [Abstract][Full Text] [Related]
28. Application of second-generation sequencing to cancer genomics.
Robison K
Brief Bioinform; 2010 Sep; 11(5):524-34. PubMed ID: 20427421
[TBL] [Abstract][Full Text] [Related]
29. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
30. Molecular diagnostics and personalized medicine in oncology: challenges and opportunities.
Normanno N; Rachiglio AM; Roma C; Fenizia F; Esposito C; Pasquale R; La Porta ML; Iannaccone A; Micheli F; Santangelo M; Bergantino F; Costantini S; De Luca A
J Cell Biochem; 2013 Mar; 114(3):514-24. PubMed ID: 22991232
[TBL] [Abstract][Full Text] [Related]
31. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
[TBL] [Abstract][Full Text] [Related]
32. Functional genomics of cancer.
Liu ET
Curr Opin Genet Dev; 2008 Jun; 18(3):251-6. PubMed ID: 18691651
[TBL] [Abstract][Full Text] [Related]
33. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
34. New generation pharmacogenomic tools: a SNP linkage disequilibrium Map, validated SNP assay resource, and high-throughput instrumentation system for large-scale genetic studies.
De La Vega FM; Dailey D; Ziegle J; Williams J; Madden D; Gilbert DA
Biotechniques; 2002 Jun; Suppl():48-50, 52, 54. PubMed ID: 12083398
[TBL] [Abstract][Full Text] [Related]
35. Personalized medicine: marking a new epoch in cancer patient management.
Diamandis M; White NM; Yousef GM
Mol Cancer Res; 2010 Sep; 8(9):1175-87. PubMed ID: 20693306
[TBL] [Abstract][Full Text] [Related]
36. Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction.
Nevins JR; Huang ES; Dressman H; Pittman J; Huang AT; West M
Hum Mol Genet; 2003 Oct; 12 Spec No 2():R153-7. PubMed ID: 12928487
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology.
Cronin M; Ross JS
Biomark Med; 2011 Jun; 5(3):293-305. PubMed ID: 21657839
[TBL] [Abstract][Full Text] [Related]
38. Transcript profiling towards personalised medicine in rheumatoid arthritis.
Verweij CL
Neth J Med; 2009 Dec; 67(11):364-71. PubMed ID: 20009112
[TBL] [Abstract][Full Text] [Related]
39. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
Glinsky GV
J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
[TBL] [Abstract][Full Text] [Related]
40. Molecular profiling of cancer--the future of personalized cancer medicine: a primer on cancer biology and the tools necessary to bring molecular testing to the clinic.
Stricker T; Catenacci DV; Seiwert TY
Semin Oncol; 2011 Apr; 38(2):173-85. PubMed ID: 21421108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
